What You Need to Know
- Health tech startup OpenEvidence sued online medical networking service Doximity for allegedly using a method called “prompt injections” to extract its proprietary AI technology.
- OpenEvidence has also sued “medical knowledge” platform Pathway Medical on similar claims.
- Though the technology at issue may be novel, said OpenEvidence’s counsel, it is still protected by the Defend Trade Secrets Act and the Computer Fraud and Abuse Act.
Archived Content
This article is part of the Law.com NewsVault archive, and access requires an additional subscription.
Already a subscriber?Log in here to access full content.
Not a subscriber?Contact us to learn more.
